Director Tsai Chen Lung adds CapsoVision (CV) shares via RSU vesting

Rhea-AI Filing Summary

CapsoVision director Tsai Chen Lung increased his direct equity stake through RSU vesting and option exercise. On June 30, he exercised derivative awards to acquire 2,022 shares of Common Stock at $7.58 per share. These shares came from Restricted Stock Units previously granted as part of equity incentive awards.

The RSUs were granted using a fair market value of $6.18 per share and vest 50% on June 30 and 50% on December 31 of the applicable year. This filing reflects vesting of one-half of the original RSU grant and delivery of the underlying shares. After the transactions, he holds 4,929 Common shares directly and 2,023 RSUs that remain outstanding.

Insider Trade Summary

2,022 shares exercised/converted

Mixed 2 txns

Insider Tsai Chen Lung

Role null

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Unit (RSU)	2,022	$0.00	--
Exercise	Common Stock	2,022	$7.58	$15K

Holdings After Transaction: Restricted Stock Unit (RSU) — 2,023 shares (Direct, null); Common Stock — 4,929 shares (Direct, null)

Footnotes (1)

1. Each Restricted Stock Unit (the "RSU") represents a contingent right to receive one share of the Issuer's common stock. The Restricted Stock Units (RSUs), the conversion of which are reported herein, were granted to the Reporting Person by the issuer as part of equity incentive grants made by the issuer on 3/19/2026 utilizing a fair market value (FMV) of a share of the issuers stock of $6.18. The RSU grant vests as to 50% of the RSUs subject to the award on June 30 of the applicable year and as to 50% of the RSUs subject to the award on December 31 of that year. This report reflects the vesting of one-half portion of the original RSU grant and the acquisition by the Reporting Person of the underlying shares.

Key Figures

Shares acquired from RSU exercise: 2,022 shares Exercise price per share: $7.58 per share Fair market value at RSU grant: $6.18 per share +3 more

6 metrics

Shares acquired from RSU exercise 2,022 shares Common Stock acquired on June 30, 2026

Exercise price per share $7.58 per share Common Stock transaction on June 30, 2026

Fair market value at RSU grant $6.18 per share Equity incentive grant on March 19, 2026

Common shares held after transaction 4,929 shares Direct ownership after June 30, 2026 transactions

RSUs outstanding after transaction 2,023 RSUs Restricted Stock Units remaining on June 30, 2026

RSU tranche vested 50% of award One-half of original RSU grant vested June 30 each year

Key Terms

Restricted Stock Unit (RSU), equity incentive grants, fair market value (FMV), vesting

4 terms

Restricted Stock Unit (RSU) financial

"Each Restricted Stock Unit (the "RSU") represents a contingent right to receive one share of the Issuer's common stock."

A restricted stock unit (RSU) is a promise from a company to give an employee company shares (or cash equal to their value) at a future date if certain conditions are met, such as staying with the company or hitting performance targets. For investors, RSUs matter because when they convert into actual shares they increase the number of shares available and can create selling pressure as employees cash out—think of them as a future paycheck paid in company stock.

equity incentive grants financial

"were granted to the Reporting Person by the issuer as part of equity incentive grants made by the issuer on 3/19/2026"

fair market value (FMV) financial

"utilizing a fair market value (FMV) of a share of the issuers stock of $6.18"

vesting financial

"The RSU grant vests as to 50% of the RSUs on June 30 and as to 50% on December 31 of that year."

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/01/2026 - 08:19 PM Accepted by SEC EDGAR 07/01/2026 - 08:19 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Tsai Chen Lung

(Last) (First) (Middle)

C/O CAPSOVISION, INC.

18805 COX AVENUE, SUITE 250

(Street)

SARATOGA CALIFORNIA 95070

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CapsoVision, Inc [ CV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock(1)	06/30/2026		M		2,022	A	$7.58	4,929	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit (RSU)	$0	06/30/2026		M			2,022	(2)	(2)	Common Stock	2,022	$0	2,023	D

Explanation of Responses:

1. Each Restricted Stock Unit (the "RSU") represents a contingent right to receive one share of the Issuer's common stock.

2. The Restricted Stock Units (RSUs), the conversion of which are reported herein, were granted to the Reporting Person by the issuer as part of equity incentive grants made by the issuer on 3/19/2026 utilizing a fair market value (FMV) of a share of the issuers stock of $6.18. The RSU grant vests as to 50% of the RSUs subject to the award on June 30 of the applicable year and as to 50% of the RSUs subject to the award on December 31 of that year. This report reflects the vesting of one-half portion of the original RSU grant and the acquisition by the Reporting Person of the underlying shares.

Remarks:

	/s/ Kang-Huai (Johnny) Wang, Attorney-in-Fact for Tsai Chen Lung	07/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did CapsoVision (CV) report for Tsai Chen Lung?

CapsoVision reported that director Tsai Chen Lung exercised equity awards to acquire 2,022 shares of Common Stock. The shares arose from vested Restricted Stock Units granted under an equity incentive program, increasing his directly held share position.

How many CapsoVision (CV) shares does Tsai Chen Lung hold after this Form 4?

After the June 30 transactions, Tsai Chen Lung holds 4,929 shares of CapsoVision Common Stock directly. He also has 2,023 Restricted Stock Units outstanding, which represent rights to receive additional shares if vesting conditions are satisfied.

What was the size of the RSU exercise in CapsoVision (CV) stock?

The filing shows an exercise of 2,022 Restricted Stock Units into 2,022 shares of CapsoVision Common Stock. This represents the vested half of an RSU grant, with the remaining portion subject to future vesting under the award’s schedule.

At what values were the CapsoVision (CV) RSUs granted and exercised?

The RSUs were granted using a fair market value of $6.18 per share as of the March 19, 2026 grant date. On June 30, 2,022 RSUs converted into Common Stock at an exercise price reflected as $7.58 per share in the non-derivative transaction line.

How do the CapsoVision (CV) RSUs for Tsai Chen Lung vest?

The RSU award vests in two equal installments each year. Fifty percent of the RSUs vest on June 30 of the applicable year, and the remaining fifty percent vest on December 31 of that year, subject to the terms of the equity incentive grant.